Transforming growth factor-β signaling pathway activation in Keratoconus.

[1]  A. Hutcheon,et al.  Human corneal fibrosis: an in vitro model. , 2010, Investigative ophthalmology & visual science.

[2]  Shin‐Sung Kang,et al.  Distribution of TGF‐β isoforms and signaling intermediates in corneal fibrotic wound repair , 2009, Journal of cellular biochemistry.

[3]  T. Sobrino,et al.  Subclinical keratoconus and inflammatory molecules from tears , 2009, British Journal of Ophthalmology.

[4]  Maja Bohac,et al.  The expression of human corneal MMP-2, MMP-9, proMMP-13 and TIMP-1 in bullous keratopathy and keratoconus. , 2008, Collegium antropologicum.

[5]  Ecosse Lamoureux,et al.  A randomized controlled trial of corneal collagen cross-linking in progressive keratoconus: preliminary results. , 2008, Journal of refractive surgery.

[6]  J. Hicks,et al.  Increased spermine oxidase expression in human prostate cancer and prostatic intraepithelial neoplasia tissues , 2008, The Prostate.

[7]  Eberhard Spoerl,et al.  Collagen crosslinking with riboflavin and ultraviolet‐A light in keratoconus: Long‐term results , 2008, Journal of cataract and refractive surgery.

[8]  S. Saika,et al.  Fibrotic disorders in the eye: Targets of gene therapy , 2008, Progress in Retinal and Eye Research.

[9]  S. Marklund,et al.  Interleukin-1alpha downregulates extracellular-superoxide dismutase in human corneal keratoconus stromal cells. , 2007, Molecular vision.

[10]  D. Böhringer,et al.  Active transforming growth factor-beta2 is increased in the aqueous humor of keratoconus patients. , 2007, Molecular vision.

[11]  T. Pihlajaniemi,et al.  Altered Expression of Type XIII Collagen in Keratoconus and Scarred Human Cornea: Increased Expression in Scarred Cornea Is Associated With Myofibroblast Transformation , 2006, Cornea.

[12]  F. J. Matthews,et al.  Keratoconus: matrix metalloproteinase-2 activation and TIMP modulation. , 2006, Biochimica et biophysica acta.

[13]  S. Saika.  TGFβ pathobiology in the eye , 2006, Laboratory Investigation.

[14]  I. Lema,et al.  Inflammatory molecules in the tears of patients with keratoconus. , 2005, Ophthalmology.

[15]  Seong-Jin Kim,et al.  Transforming Growth Factor-β: Biology and Clinical Relevance , 2005 .

[16]  H. Sheardown,et al.  Growth factors in the anterior segment: role in tissue maintenance, wound healing and ocular pathology. , 2004, Experimental eye research.

[17]  N. Vij,et al.  Microarray studies reveal macrophage-like function of stromal keratocytes in the cornea. , 2004, Investigative ophthalmology & visual science.

[18]  A. Mauviel,et al.  TGF-β-induced SMAD signaling and gene regulation : consequences for extracellular matrix remodeling and wound healing , 2004 .

[19]  Andrew Leask,et al.  TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[20]  Y. Rabinowitz.  The genetics of keratoconus. , 2003, Ophthalmology clinics of North America.

[21]  D. Wakefield,et al.  Regulation of MMPs and TIMPs by IL-1beta during corneal ulceration and infection. , 2003, Investigative ophthalmology & visual science.

[22]  A. Phillips,et al.  TGF-beta1-mediated fibroblast-myofibroblast terminal differentiation-the role of Smad proteins. , 2003, Experimental cell research.

[23]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[24]  S. Collier.  Is the corneal degradation in keratoconus caused by matrix‐metalloproteinases? , 2001, Clinical & experimental ophthalmology.

[25]  A. Ljubimov,et al.  Altered expression of growth factors and cytokines in keratoconus, bullous keratopathy and diabetic human corneas. , 2001, Experimental eye research.

[26]  F. Oppenheimer,et al.  Role of transforming growth factor‐ β1 in the progression of chronic allograft nephropathy , 2001 .

[27]  D M Meisler,et al.  Keratocyte apoptosis associated with keratoconus. , 1999, Experimental eye research.

[28]  J. Sugar,et al.  Expression of degradative enzymes and protease inhibitors in corneas with keratoconus. , 1998, Investigative ophthalmology & visual science.

[29]  G. Boivin,et al.  TGFbeta2 knockout mice have multiple developmental defects that are non-overlapping with other TGFbeta knockout phenotypes. , 1997, Development.

[30]  J. Massagué,et al.  Distinct transforming growth factor-beta (TGF-beta) receptor subsets as determinants of cellular responsiveness to three TGF-beta isoforms. , 1990, The Journal of biological chemistry.

[31]  S. Saika.  TGFbeta pathobiology in the eye. , 2006, Laboratory investigation; a journal of technical methods and pathology.

[32]  Seong-Jin Kim,et al.  Transforming growth factor-beta : biology and clinical relevance. , 2005, Journal of biochemistry and molecular biology.

[33]  A. Mauviel,et al.  TGF-beta-induced SMAD signaling and gene regulation: consequences for extracellular matrix remodeling and wound healing. , 2004, Journal of dermatological science.

[34]  F. Oppenheimer,et al.  Role of transforming growth factor-beta1 in the progression of chronic allograft nephropathy. , 2001, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[35]  M. Madigan,et al.  Expression of membrane-type 1 matrix metalloproteinase (MT1-MMP) and MMP-2 in normal and keratoconus corneas. , 2000, Current eye research.

[36]  C. Teng.  Electron Microscope Study of The Pathology of Keratoconus: Part I* , 1963 .

[37]  C. Teng.  Electron microscope study of the pathology of keratoconus: I. , 1963, American journal of ophthalmology.